MyBlueDotsFrenelle Pharma Officially Launches: CEO Missling Attends JPM 2025 Representing Frenelle’s Portfolio MyBlueDots5 months ago01 mins PLYMOUTH, Minn.–(BUSINESS WIRE)–Our proprietary technology enables precise, sustained delivery of medications, reducing dosing frequency while enhancing efficacy & patient compliance Go to Source Author: Post navigation Previous: AI can enhance cervical cancer detection with medical image recognitionNext: China Pharmaceutical Regulatory Affairs Training Course: How to Gain and Maintain a Successful Marketing Authorisation in the PRC, Including Hong Kong, Macau and Taiwan (ONLINE EVENT: April 8-9, 2025) – ResearchAndMarkets.com
Neighborly help in the brain: Cerebral cortex networks rapidly reorganize to compensate for lost neurons MyBlueDots12 hours ago 0
FDA approves pembrolizumab for resectable head and neck cancer with PD-L1 expression MyBlueDots18 hours ago 0
US measles count nears 1,200 cases as Ohio officials confirm 3 outbreaks are over MyBlueDots18 hours ago 0
2020 to 2022 saw nearly 2 million annual emergency room visits for dental issues MyBlueDots1 day ago 0